News
Letzte Aktualisierung: November 16, 2021
Vaccination for children under eleven
China plans to fully vaccinate all children between the ages of three and eleven against COVID-19 by the end of the year. China's National Health Commission recently announced that more than 84 million children between the ages of three and eleven have already received the first dose of the vaccine.
"Vaccinating children is voluntary," said Wang Dengfeng, an official from the Ministry of Education, at a press conference. He praised the fact that out of 160 million children in the age group of three to eleven, half have already received the vaccination.
In June, the Chinese regulatory authority had already approved the vaccines by Sinovac and Sinopharm for the age group between 3 and 17 years. So far, vaccinations of older children have been prioritized. As a result, the vaccination rate of 12 to 17-year-olds is said to be 90 percent. However, after outbreaks in elementary and primary schools, Beijing now appears to have decided to vaccinate the younger age groups as well. In a recent study published by the medical journal Lancet, Sinopharm's vaccine for children was found to be safe and well-tolerated.
In the United Arab Emirates, Argentina and Chile, the two Chinese vaccines have received emergency approval for children aged three and older. Hong Kong has also been reviewing Sinovac for approval for children of three years and older since Monday, according to Bloomberg. On Monday, Israel approved Biontech's Covid vaccine for children five years and older. The US also vaccinates children above five. Biontech has also applied in the EU for approval of its vaccine for five to eleven-year-olds. A decision by the European Medicines Agency (EMA) is expected before Christmas. niw
"Vaccinating children is voluntary," said Wang Dengfeng, an official from the Ministry of Education, at a press conference. He praised the fact that out of 160 million children in the age group of three to eleven, half have already received the vaccination.
In June, the Chinese regulatory authority had already approved the vaccines by Sinovac and Sinopharm for the age group between 3 and 17 years. So far, vaccinations of older children have been prioritized. As a result, the vaccination rate of 12 to 17-year-olds is said to be 90 percent. However, after outbreaks in elementary and primary schools, Beijing now appears to have decided to vaccinate the younger age groups as well. In a recent study published by the medical journal Lancet, Sinopharm's vaccine for children was found to be safe and well-tolerated.
In the United Arab Emirates, Argentina and Chile, the two Chinese vaccines have received emergency approval for children aged three and older. Hong Kong has also been reviewing Sinovac for approval for children of three years and older since Monday, according to Bloomberg. On Monday, Israel approved Biontech's Covid vaccine for children five years and older. The US also vaccinates children above five. Biontech has also applied in the EU for approval of its vaccine for five to eleven-year-olds. A decision by the European Medicines Agency (EMA) is expected before Christmas. niw
